Recognising excellence in endocrinology, ESE announces the winners of its prestigious Awards for 2025
Date: 21 October 2024
The European Society of Endocrinology (ESE) is delighted to announce the winners of the 2025 ESE Awards.
The winners of the Society’s prestigious annual Awards for 2025 have all contributed to improving knowledge and expertise in endocrinology and have helped drive innovation and progression across the field.
Each of these deserving winners will be presenting a plenary lecture at the Joint Congress of ESPE and ESE 2025 which will be held in Copenhagen, Denmark, from 10-13 May 2025.
Jérôme Bertherat, President of the European Society of Endocrinology (ESE) commented: “We had some outstanding candidates for the 2025 ESE Awards. Our Award winners are exceptional, they have demonstrated great leadership and have made a huge contribution to both research and to patient care in the field of endocrinology. They are fully deserving winners of these prestigious Awards, and I know they will deliver excellent Award lectures at the Joint Congress of ESPE and ESE 2025 next May.”
The 2025 Geoffrey Harris Award is being presented to Thierry Brue (France). This Award recognises outstanding researchers in the field of neuroendocrinology.
Thierry Brue, MD, PhD, is Professor of endocrinology at Aix-Marseille University (AMU, Marseille, France), and endocrinologist at the department of Endocrinology of Conception University Hospital, and coordinator of the national and European (Endo-ERN) rare disease reference centre for pituitary disorders (HYPO). Since 2019, he has been the Director of the Aix-Marseille University Institute for Rare Diseases, MarMaRa.
Thierry’s research activities include clinical research in pituitary disorders, especially participation as investigator in international multicentre clinical trials, experimental research as group leader in the Marseille Medical Genetics AMU-INSERM Laboratory of Frédérique Magdinier and coordination of a research network on genetically determined pituitary hormone deficiency (GENHYPOPIT). He has co-authored 330+ articles referenced in PubMed (WoS h-index: 60+; total times cited 10000+, Google Scholars 79+), and is a member of several international societies of endocrinology, past-President (2018-2020) of the European Neuroendocrine Association (ENEA), and recipient of the Rolf-Gaillard Prize 2023.
The European Hormone Medal is awarded to an international researcher who has made significant contributions to the field of basic or clinical endocrinology. This year's Award goes to Krishna Chatterjee (United Kingdom).
Krishna Chatterjee is Professor of Endocrinology at the Institute of Metabolic Science at the University of Cambridge, Consultant Endocrinologist at Cambridge University Hospitals and Director of the National Institute for Health Research (NIHR) Cambridge Clinical Research Facility.
Krishna is distinguished for his contribution to the molecular basis of endocrine disorders and its application to clinical medicine. His discoveries of genetic disorders of thyroid gland formation, regulation of hormone synthesis and hormone action, have advanced fundamental knowledge at different levels of the thyroid axis.
He has translated his research into technologies (biochemical, genetic, biomarkers) that comprise an internationally recognised service for the diagnosis and management of disorders of thyroid hormone action and trials therapies for these conditions.
The European Endocrine Nurse Award is awarded to endocrine nurses and teams who have made a truly significant contribution to the advancement of endocrinology nursing. This year’s Award is presented to Eugenia Vlachou (Greece).
Eugenia Vlachou has had a significant effect on the training of endocrine nurses in Greece, demonstrated through their great work and the treatment of patients.
Eugenia holds the position of Professor of Endocrinology and Gynaecology Nursing at the Department of Nursing in the University of West Attica, Athens, Greece. Throughout her tenure, she has held various administrative roles, contributing significantly to the academic and clinical development of the department. She is the Director of the MSc Programme on Management of Chronic Diseases, and she is also academically responsible for the specialty of Diabetes Care.
She obtained her degree in Nursing from the National and Kapodistrian University of Athens. She further pursued an MSc in Public Health and completed her PhD in Gynaecological Endocrinology at the same university. During her early career, she worked at the esteemed Endocrinology Clinics of The Evangelismos Hospital in Athens, where she received her Medical-Surgical Nursing Specialty. She later specialised in the UK in Diabetes Nursing.
Eugenia has served as a member of the Executive Committee of the Hellenic Regulatory Body of Nurses for six years, and as a member of the European Society of Endocrinology (ESE) Nurse Committee for four years. She is currently a member of the Foundation of European Nurses in Diabetes (FEND) Executive Committee and maintains active memberships in the Hellenic Endocrinology Society and the Hellenic Diabetes Society. Her extensive professional network and leadership roles reflect her dedication to advancing the field of Endocrinology and Diabetes nursing, both nationally and internationally.
The Clinical Endocrinology Journal Foundation Award is given for clinical research that addresses aspects of endocrinology at the forefront of clinical practice and is sponsored by the Clinical Endocrinology Journal Foundation. This year's Award goes to Massimo Terzolo (Italy).
Massimo Terzolo’s exceptional contributions to clinical research have had a tremendous impact on adrenocortical cancer treatment to improve patient care, making him a highly deserving recipient of this Award.
Massimo Terzolo, MD, PhD, is a Full Professor of Internal Medicine at the University of Turin, where he serves as Director of the Department of Clinical and Biological Sciences and Head of the Division of Internal Medicine at University Hospital San Luigi Gonzaga in Orbassano. Massimo has significantly advanced the field of adrenal disease and endocrine oncology, particularly through his leadership in groundbreaking clinical trials.
He coordinated the pivotal ADIUVO trial on adjuvant mitotane therapy for non-metastatic adrenocortical carcinoma and was instrumental in the FIRMACT trial for advanced stages of the disease. His work has driven crucial progress in therapeutic approaches to adrenocortical carcinoma, with landmark publications in The Lancet Diabetes & Endocrinology and The New England Journal of Medicine. Additionally, he has co-authored the European Society of Endocrinology’s Guidelines on Adrenocortical Carcinoma and Adrenal Incidentalomas, reinforcing best practices in endocrinology.
A leader within the European Network for the Study of Adrenal Tumors (ENSAT), Massimo heads the Adrenocortical Carcinoma working group. His prolific research, with over 270 peer-reviewed publications, has earned more than 17,000 citations, attesting to his profound impact on the field. He also serves on editorial boards for leading journals in endocrinology.
The European Journal of Endocrinology Award is presented to a candidate who has significantly contributed to the advancement of knowledge in the field of endocrinology through publication. This year’s Award goes to Kashyap Patel (United Kingdom).
Kashyap Patel is a world-leading expert and highly awardable for his impressive publication record which has significantly advanced knowledge in the field of monogenic diabetes and directly benefited patients (H-index 29, citations 3771, overall median citation percentile – 81st).
Kashyap is an Associate Professor and Consultant Physician in Diabetes and Endocrinology at University of Exeter Medical School, Exeter. He is a Wellcome Trust Career Development Fellow and his main area of research includes understanding the genetics of diabetes with a focus on Monogenic and Type 1 diabetes. His research uses next-generation sequencing technology and large data sets to improve diagnosis and understanding of monogenic diabetes in humans.
He was a Wellcome Trust PhD Research Fellow in the prestigious MRC Protein Phosphorylation Unit in Dundee, where he was awarded his PhD studying the glucose metabolism in the liver. After his PhD, he obtained a Wellcome Trust Postdoctoral Fellowship to study monogenic diabetes in Exeter with Professor Andrew Hattersley and Professor Sian Ellard. He is also the recipient of prestigious Young Investigator awards from Diabetes UK and EASD-SGGD for his work in monogenic diabetes.
The Jens Sandahl Christiansen Award is presented to endocrinologists for a specific piece of research or project which contributes to our understanding of metabolism. This award is split into clinical and basic science. The recipients of the Award for 2025 are Ana Djordjevic (Serbia) for Basic Science and Alessandro Prete (United Kingdom) for Clinical Science.
Ana Djordjevic has demonstrated exceptional commitment to research and has published three book chapters and over 60 scientific papers in international journals, giving her an excellent publication score.
Ana is a Principal Research Fellow at the Institute for Biological Research Siniša Stanković (IBISS) at the University of Belgrade. She received her PhD from the Faculty of Biology at the University of Belgrade in 2010, where she completed her undergraduate studies in Molecular Biology and Physiology. She is the head of the Department of Biochemistry at IBISS, and has participated in several national and international projects, most recently in the Twinning project STRIMHealth. Ana is currently Principal Investigator of a proof-of-concept project, Probiotic bacteria for reducing liver steatosis, funded by the World Bank SAIGE project.
Ana’s early research focused on stress biology, and over the last 10 years, her research has remained in the field of molecular endocrinology but has focused mainly on diet-induced metabolic disorders, particularly type 2 diabetes and obesity. She is currently the Vice President of the Serbian Society for Molecular Biology.
Alessandro Prete has an excellent publication record and must be commended for his focused and potentially impactful clinical research project.
Alessandro is a Clinical Associate Professor of Endocrinology at the Department of Metabolism and Systems Science, University of Birmingham, UK. He obtained his PhD from the same University in 2022 and is also a Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, UK.
His area of research focuses on functioning adrenal tumours, endocrine hypertension, and adrenal insufficiency, combining clinical trials and experimental medicine studies. As well as receiving awards at both national and international conferences for his work, Alessandro has over 40 peer-reviewed publications.
The Transatlantic Alliance Award 2025 winner will be announced later this year. Nominations for the ESE’s 2026 Awards will open in November 2024.
18/10/2024